Developpement et diffusion de METALGEN Un ensemble d'applications informatiques pour l'enseignement du metabolisme

Available from INIST (FR), Document Supply Service, under shelf-number : AR 16703 / INIST-CNRS - Institut de l'Information Scientifique et TechniqueSIGLEMinistere de l'Education Nationale de la Recherche et de la Technologie, 75 - Paris (France)FRFranc

Cancer and non-cancer brain and eye effects of chronic low-dose ionizing radiation exposure

<p>Abstract</p> <p><b>Background</b></p> <p>According to a fundamental law of radiobiology (“Law of Bergonié and Tribondeau”, 1906), the brain is a paradigm of a highly differentiated organ with low mitotic activity, and is thus radio-resistant. This assumption has been challenged by recent evidence discussed in the present review.</p> <p><b>Results</b></p> <p>Ionizing radiation is an established environmental cause of brain cancer. Although direct evidence is lacking in contemporary fluoroscopy due to obvious sample size limitation, limited follow-up time and lack of focused research, anecdotal reports of clusters have appeared in the literature, raising the suspicion that brain cancer may be a professional disease of interventional cardiologists. In addition, although terminally differentiated neurons have reduced or mild proliferative capacity, and are therefore not regarded as critical radiation targets, adult neurogenesis occurs in the dentate gyrus of the hippocampus and the olfactory bulb, and is important for mood, learning/memory and normal olfactory function, whose impairment is a recognized early biomarker of neurodegenerative diseases. The head doses involved in radiotherapy are high, usually above 2 Sv, whereas the low-dose range of professional exposure typically involves lifetime cumulative whole-body exposure in the low-dose range of < 200 mSv, but with head exposure which may (in absence of protection) arrive at a head equivalent dose of 1 to 3 Sv after a professional lifetime (corresponding to a brain equivalent dose around 500 mSv).</p> <p><b>Conclusions</b></p> <p>At this point, a systematic assessment of brain (cancer and non-cancer) effects of chronic low-dose radiation exposure in interventional cardiologists and staff is needed.</p

Wood machining with a focus on French research in the last 50 years

International audienceContext: Woodcutting is a very old technology but scientific research is scarce on the subject. In the last 50 years much work on basic mechanisms as well as industrial processes has been done in France. Aims: The specific nature of wood introduces strong differences between wood and metal cutting processes. The paper focuses on French teams' contributions. Results: The basic aspects of the tool–material interaction for different basic modes in woodcutting are highlighted. In primary conversion such as sawing, veneer cutting or green wood chipping, huge progress comes from automation and the possibility of linking the process to log and product quality through new sensors. In secondary processing much has been done on the links between the cutting process, surface qualification and the properties of these surfaces for further processing, such as gluing or coating. Tool wear depends on the cutting process, timber quality, and species. Trade-offs are required in tool technology and coating technologies may improve tool life. Conclusion: A large amount of knowledge and innovation has come from 50 years of worldwide research effort, with France being particularly active in this period. The transfer of skills from metals cutting industry was often a key, but much is needed to move closer to both metal cutting sector and woodcutting skills among craftsmen

ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19

The International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) COVID-19 dataset is one of the largest international databases of prospectively collected clinical data on people hospitalized with COVID-19. This dataset was compiled during the COVID-19 pandemic by a network of hospitals that collect data using the ISARIC-World Health Organization Clinical Characterization Protocol and data tools. The database includes data from more than 705,000 patients, collected in more than 60 countries and 1,500 centres worldwide. Patient data are available from acute hospital admissions with COVID-19 and outpatient follow-ups. The data include signs and symptoms, pre-existing comorbidities, vital signs, chronic and acute treatments, complications, dates of hospitalization and discharge, mortality, viral strains, vaccination status, and other data. Here, we present the dataset characteristics, explain its architecture and how to gain access, and provide tools to facilitate its use